The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils

AIDS

Volumn 14, Issue 8, 2000, Pages 931-938

  Florio, Giovanni ^a   Petraroli, Angelica ^a   Patella, Vincenzo ^a   Triggiani, Massimo ^a   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Basophils; Fc RI; Gp120; Histamine; HIV 1; IL 4; Interleukin 4

Indexed keywords

GLYCOPROTEIN GP 120; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; PEPTIDOLEUKOTRIENE; SUPERANTIGEN; SYNTHETIC PEPTIDE; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BASOPHIL; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE RELEASE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LEUKOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, ANTI-IDIOTYPIC; BASOPHILS; BINDING SITES, ANTIBODY; CYCLOSPORINE; CYSTEINE; HISTAMINE RELEASE; HIV ENVELOPE PROTEIN GP120; HIV-1; HIV-2; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; INTERLEUKIN-4; KINETICS; LEUKOTRIENE C4; LEUKOTRIENES; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, IGE; SUPERANTIGENS; TACROLIMUS;

EID: 0034087356     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200005260-00004     Document Type: Article

References (53)

1. 1. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996, 384:529-534.
2. 2. Barre-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 1983, 220:868-871.
3. 3. Gallo RC, Salahuddin SZ, Popovic M et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224:500-503.
4. 4. Kowalski M, Potz J, Basiripour L et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 1987, 237:1351-1355.
5. 5. Lu M, Blacklow SC, Kim PS. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol 1995, 2:1075-1082.
6. 6. Starcich BR, Hahn BH, Shaw GM et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986, 45:637-648.
7. 7. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659.
8. 8. Moore JP. Coreceptors: implications for HIV pathogenesis and therapy. Science 1997, 276:51-52.
9. 9. Feng F, Broder CC, Kennedy PE, Berger EA. HIV-1-entry cofactor: functional cDNA cloning of a seven-transmembrane, G-protein-coupled receptor. Science 1996, 272:872-877.
10. H3 gene products: natural ligands for HIV gp120. Science 1993, 261:1588-1591.
11. 11. Karray S, Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc Natl Acad Sci USA 1997, 94:1356-1360.
12. 12. Silverman GJ. B-cell superantigens. Immunol Today 1997, 18:379-386.
13. 13. Karray S, Juompan L, Maroun RC, Isenberg D, Silverman GJ, Zouali M. Structural basis of the gp120 superantigen-binding site on human immunoglobulins. J Immunol 1998, 161:6681-6688.
14. H3 immunoglobulin binding to staphylococcal protein A. J Exp Med 1993, 178:331-336.
15. H3 family antibodies bind domain D of staphylococcal protein A. J Immunol 1995, 154:6437-6445.
16. 16. Pantalaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993, 328:327-335.
17. 17. Viganò A, Principi N, Crupi L, Onorato J, Zuccotti GV, Salvaggio A. Elevation of IgE in HIV-infected children and its correlation with the progression of disease. J Allergy Clin Immunol 1995, 95:627-632.
18. 18. Paganelli R, Scala E, Mezzaroma I et al. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995, 95:995-1003.
19. 19. Koutsonikolis A, Nelson RP, Fernandez-Caldas E et al. Serum total and specific IgE levels in children infected with human immunodeficiency virus. J Allergy Clin Immunol 1996, 97: 692-697.
20. 20. Secord EA, Kleiner GI, Auci DL et al. IgE against HIV proteins in clinically healthy children with HIV disease. J Allergy Clin Immunol 1996, 98:979-984.
21. 21. Milazzo F, Piconi S, Trabattoni D et al. Intractable pruritus in HIV infection: immunologic characterization. Allergy 1999, 54:266-272.
22. 22. Patella V, Bouvet J-P, Marone G. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J Immunol 1993, 151:5685-5698.
23. 23. Patella V, Casolaro V, Ciccarelli A, Pettit GR, Columbo M, Marone G. The antineoplastic bryostatins affect human basophils and mast cells differently. Blood 1995, 85:1272-1281.
24. H3 region of IgE. J Immunol 1998, 161:5647-5655.
25. 25. Galli SJ. New concepts about the mast cell. N Engl J Med 1993, 328:257-265.
26. 26. Bradding BP, Feather IH, Howarth PH et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992, 176:1381-1386.
27. 27. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993, 177:605-611.
28. 28. MacGlashan D, White JM, Huang SK, Ono SJ, Schroeder JT, Lichtenstein LM. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1994, 152:3006-3016.
29. 29. de Paulis A, Minopoli G, Arbustini E et al. Stem cell factor is localized in, released from, and cleaved by human mast cells. J Immunol 1999, 163:2799-2808.
30. H family-specific binding interactions with human Igs. J Immunol 1996, 157:4496-4502.
31. 31. Siraganian RP. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Analyt Biochem 1974, 57:383-394.
32. 32. Snedecor GW, Cochran WG. Statistical Methods. Ames, IA: Iowa State University Press;1980.
33. 33. Marone G, Casolaro V, Paganelli R, Quinti I. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 1989, 93:246-252.
34. 34. Cirillo R, Triggiani M, Siri L et al. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol 1990, 144: 3891-3897.
35. 35. de Paulis A, Cirillo R, Ciccarelli A, Condorelli M, Marone G. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human FcεRI cells. J Immunol 1991, 146:2374-2381.
36. 36. Casolaro V, Spadaro G, Patella V, Marone G. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. J Immunol 1993, 151:5563-5573.
37. 37. Romagnani P, de Paulis A, Beltrame C et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor (CCR3) and are attracted by CCR3-binding chemokines. Am J Pathol 1999, 155:1195-1204.
38. 38. de Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol 1996, 98:152-164.
39. 39. Goodglick L, Zevit N, Neshat MS, Braun J. Mapping the Ig superantigen-binding site of HIV-1 gp120. J Immunol 1995, 155:5151-5159.
40. 40. Gelderblom HR, Hausmann EHS, Özel M, Pauli G, Koch MA. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 1987, 156:171-176.
41. 41. Del Prete G, Maggi E, Parronchi P et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988, 140:4193-4198.
42. 42. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
43. 43. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994, 12:227-257.
44. - T-cells. AIDS Res Hum Retroviruses 1990, 6:427-429.
45. 45. Shor-Posner G, Miguez-Burbano MJ, Lu Y et al. Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus-1 disease. J Allergy Clin Immunol 1995, 95:886-892.
46. 46. Israël-Biet D, Labrousse F, Tourani JM, Sors H, Andrieu JM, Even P. Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. J Allergy Clin Immunol 1992, 89:68-75.
47. 47. Clerici M, Hakim FT, Venzon DJ et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993, 91:759-765.
48. 48. Clerici M, Shear GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993, 14:107.
49. 49. Burtin C, Blanche S, Galoppin L, Merval R, Griscelli C, Scheinmann P. Blood histamine levels in HIV-1-infected infants and children. Int Arch Allergy Appl Immunol 1990, 91:142-144.
50. 50. Pedersen M, Nielsen CM, Permin H. HIV antigen-induced release of histamine from basophils from HIV infected patients. Allergy 1991, 46:206-212.
51. 51. Karpas A, Lowdell M, Jacobson SK, Hill F. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc Natl Acad Sci USA 1992, 89:8351-8355.
52. 52. Thall M, Bukovsky A, Kondo E et al. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372:363-365.
53. 53. Andrieu J-M, Even P, Venet A et al. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin Immunol Immunopathol 1988, 46:181-198.